Allianz Asset Management
AGN

Allianz Asset Management’s Allergan Inc AGN Stock Holding History

Allianz Asset Management’s Portfolio AGN Stock Details AGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q1 		– Sell
-779,716
Closed -$166M – 2497
2014
Q4 		$166M Sell
779,716
-124,388
-14% -$24.7M 0.18% 110
2014
Q3 		$161M Sell
904,104
-127,822
-12% -$21.2M 0.19% 112
2014
Q2 		$175M Sell
1,031,926
-184,007
-15% -$28.6M 0.22% 105
2014
Q1 		$151M Buy
1,215,933
+113,225
+10% +$13.8M 0.18% 122
2013
Q4 		$122M Sell
1,102,708
-490,282
-31% -$46.8M 0.16% 163
2013
Q3 		$144M Sell
1,592,990
-236,738
-13% -$21.3M 0.19% 123
2013
Q2 		$154M Buy
+1,829,728
New +$190M 0.22% 106

Other funds holding AGN

California Public Employees Retirement System
California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return
CA
Commerzbank Aktiengesellschaft Frankfurt, Germany $4.78B AUM 25.31% 1-Year Est. Return
ECM
Everence Capital Management Goshen, Indiana $1.64B AUM 26.46% 1-Year Est. Return
HFS
HL Financial Services Louisville, Kentucky $6.5B AUM 9.56% 1-Year Est. Return
AIM
Advantage Investment Management Cedar Rapids, Iowa $128M AUM 0.94% 1-Year Est. Return

Allianz Asset Management's AGN Position: Q1 2015 in Review

Allianz Asset Management sold out of Allergan Inc (AGN) in Q1 2015, closing a stake of 779,716 shares — an estimated $166M sold.

Allianz Asset Management first reported a position in AGN in Q2 2013 and held it in 7 quarters. The position peaked at $175M in Q2 2014. 5 funds tracked by Wall St. Rank hold AGN as of Q1 2015.

  • Allianz Asset Management reported no remaining Allergan Inc position as of Q1 2015 after selling out during the quarter.
  • Allianz Asset Management sold 779,716 Allergan Inc shares in Q1 2015, an estimated $166M.
  • Allianz Asset Management first reported a position in Allergan Inc in Q2 2013 and held it in 7 quarters.
  • Allianz Asset Management's Allergan Inc position peaked at $175M in Q2 2014.
  • 5 funds tracked by Wall St. Rank held Allergan Inc as of Q1 2015.

Based on Allianz Asset Management's 13F filing for Q1 2015, filed 15 May 2015.